<h2>In Vivo CRO Market Growing at a CAGR of 8.2% | Insights &amp; Forecasts 2023&ndash;2031</h2>
<p>According to Straits Research, The global <strong><a href="https://straitsresearch.com/report/in-vivo-cro-market">In Vivo CRO Market</a></strong>&nbsp;size was valued at <strong>USD 4.23 Billion</strong> in <strong>2022</strong> and is projected to reach from <strong>USD XX Billion</strong> in <strong>2023</strong> to <strong>USD 8.6 Billion</strong> in <strong>2031</strong>, growing at a CAGR of <strong>8.2%</strong> during the forecast period (<strong>2023&ndash;2031</strong>).</p>
<img src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi8vTz6rJQ0BU-zaIggYV6-sSMLyFMxxOqxL47finS8yvIIynz9p-qoQhMLKgqRaOnNh_O_qGoqRVACYw9lKtQND-Kzt5yRpjIhUkSZUESwuYl8IURf2WTlna86eMO8N5FtOuZBHwYPZ8J0N7gWeht_4yHDoz1MfW498ZFQudGlFuZQNL-MpBMXrfkQxw/s700/7.jpg">
<p>The In Vivo CRO market is witnessing significant growth due to an increasing demand for contract research organizations (CROs) in drug development, with an emphasis on in vivo testing for pharmaceutical, biotechnology, and medical device industries. CROs offering in vivo services are playing an important role in accelerating the drug discovery process, making them highly valuable in clinical trials.</p>
<h3>Market Key Trends</h3>
<p>The In Vivo CRO market is driven by several factors including increased demand for animal testing in drug development, as it provides valuable data on the safety and efficacy of potential treatments. Additionally, a growing need for preclinical testing and support in clinical trials for new drugs is driving the market.</p>
<h3>Driving Factors</h3>
<p>Several factors are propelling the growth of the In Vivo CRO market. One major factor is the increasing demand for animal testing in drug development, as it provides valuable data on the safety and efficacy of potential treatments. Additionally, a growing need for preclinical testing and support in clinical trials for new drugs is driving the market.</p>
<p>Technological advancements in animal models and testing methods are also expanding the scope of services offered by In Vivo CROs. The adoption of high-precision imaging techniques and automation in testing further contributes to the growth of the market, enabling better results and faster time-to-market for drugs.</p>
<p><strong>Download Free Sample Report with&nbsp;Complimentary Analyst Consultation : <a href="https://straitsresearch.com/report/in-vivo-cro-market/request-sample">https://straitsresearch.com/report/in-vivo-cro-market/request-sample</a><br /></strong></p>
<h3>Opportunities in the In Vivo CRO Market</h3>
<p>The rise of biopharmaceuticals presents substantial opportunities for the In Vivo CRO market. As pharmaceutical companies increase their investments in biologics, vaccines, and gene therapies, the demand for specialized testing and research services continues to grow. This, in turn, creates a potential revenue opportunity for CROs providing tailored in vivo services for biotech firms.</p>
<p>Emerging markets, such as Asia-Pacific, are increasingly becoming important hubs for contract research, driven by cost-effectiveness, availability of skilled researchers, and favorable regulatory frameworks. Companies are increasingly outsourcing preclinical and clinical trials to these regions, opening new avenues for the In Vivo CRO market.</p>
<h3>In Vivo CRO Market Segmentation</h3>
<ul>
<li><strong>By Type</strong>
<ul>
<li>Rodent</li>
<li>Non-Rodent</li>
</ul>
</li>
<li><strong>By Disease Indication</strong>
<ul>
<li>Autoimmune/inflammation conditions</li>
<li>Pain management</li>
<li>Oncology</li>
<li>CNS conditions</li>
<li>Diabetes</li>
<li>Obesity</li>
<li>Others</li>
</ul>
</li>
<li><strong>By GLP Type</strong>
<ul>
<li>Non-GLP</li>
<li>GLP Toxicology</li>
</ul>
</li>
</ul>
<h3>List of Key Players in the In Vivo CRO Market</h3>
<ul>
<li>Charles River Laboratories</li>
<li>Covance Inc.</li>
<li>Labcorp Drug Development</li>
<li>WuXi AppTec</li>
<li>Evotec AG</li>
<li>Pharmaron</li>
<li>BioDuro-Sundia</li>
<li>Harlan Laboratories</li>
<li>ICON plc</li>
<li>KCR, Inc.</li>
<li>PPD Inc.</li>
</ul>
<h3>Conclusion</h3>
<p>The In Vivo CRO market is expected to continue growing at a strong pace due to an increased focus on drug development and the growing need for outsourced preclinical and clinical trial services. As in vivo testing becomes increasingly crucial in identifying new therapies for chronic and complex diseases, the demand for In Vivo CRO services will continue to rise.</p>
<h3>Why Straits Research?</h3>
<p>Straits Research is a leading provider of business intelligence, offering comprehensive insights into the In Vivo CRO market. Our detailed reports are backed by robust data analytics and market research, ensuring valuable and actionable insights to help businesses stay ahead of the curve.</p>
<h3><strong>Contact Us</strong></h3>
<p>Email:&nbsp;<a rel="">sales@straitsresearch.com</a><br />Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)</p>
<p>For more details on the In Vivo CRO market and customized reports, feel free to reach out to us.</p>
